Published February 9, 2022
| Version v1
Journal article
Open
A functional genomic approach to actionable gene fusions for precision oncology
Creators
-
Li, Jun1
-
Lu, Hengyu2
-
Ng, Patrick Kwok-Shing1
-
Pantazi, Angeliki3
-
Ip, Carman Ka Man1
- Jeong, Kang Jin1
- Amador, Bianca1
-
Tran, Richard1
-
Tsang, Yiu Huen1
-
Yang, Lixing4
- Song, Xingzhi1
-
Dogruluk, Turgut2
- Ren, Xiaojia3
-
Hadjipanayis, Angela3
- Bristow, Christopher A.1
-
Lee, Semin3
- Kucherlapati, Melanie3
- Parfenov, Michael3
- Tang, Jiabin1
-
Seth, Sahil1
- Mahadeshwar, Harshad S.1
-
Mojumdar, Kamalika1
- Zeng, Dong1
-
Zhang, Jianhua1
- 1. University of Texas MD Anderson Cancer Center
- 2. Baylor University
- 3. Harvard University
- 4. University of Chicago
Description
Fusion genes represent a class of attractive therapeutic targets. Thousands of fusion genes have been identified in patients with cancer, but the functional consequences and therapeutic implications of most of these remain largely unknown. Here, we develop a functional genomic approach that consists of efficient fusion reconstruction and sensitive cell viability and drug response assays. Applying this approach, we characterize ∼100 fusion genes detected in patient samples of The Cancer Genome Atlas, revealing a notable fraction of low-frequency fusions with activating effects on tumor growth. Focusing on those in the RTK-RAS pathway, we identify a number of activating fusions that can markedly affect sensitivity to relevant drugs. Last, we propose an integrated, level-of-evidence classification system to prioritize gene fusions systematically. Our study reiterates the urgent clinical need to incorporate similar functional genomic approaches to characterize gene fusions, thereby maximizing the utility of gene fusions for precision oncology.
Notes
Data availability
All the data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Correspondence and requests for materials should be addressed to A.T. (athalham@sissa.it) and L.B. (laura.ballerini@sissa.it).
Files
sciadv.abm2382.pdf
Files
(2.4 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:7f804df41fce7107c1a481ca9c911b7d |
1.2 MB | Preview Download |
|
Supplementary materials md5:0b5f89ba8787bf1069c7d054019a1f1f |
1.2 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1126/sciadv.abm2382
- Other
- oai:uchicago.tind.io:10907
Funding
- National Institutes of Health
- CA217842
- National Institutes of Health
- CA217685
- National Institutes of Health
- CA098258
- National Institutes of Health
- CA209851
- National Institutes of Health
- CA144025
- National Institutes of Health
- CA168394
- National Institutes of Health
- CA016672
- National Institutes of Health
- CA125123
- Cancer Prevention and Research Institute of Texas
- RP150535
- Cancer Prevention and Research Institute of Texas
- RP120046
- Cancer Prevention and Research Institute of Texas
- RP140102
- Catching the Dream
- National Institutes of Health
- CA25347
- Cancer Prevention and Research Institute of Texas
- RR160021